Henry Hagopian III - 20 Nov 2023 Form 4/A - Amendment Insider Report for Annovis Bio, Inc. (ANVS)

Role: Chief Financial Officer
Signature: /s/ Henrey Hagopian III
Issuer symbol: ANVS
Transactions as of: 20 Nov 2023
Net transactions value: +$5,002
Form type: 4/A - Amendment
Filing time: 22 Nov 2023, 16:21:13 UTC
Date Of Original Report: 21 Nov 2023
Previous filing: 11 Apr 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANVS	Common Stock	Award	$5,002	+820	+82%	$6.10	1,820	20 Nov 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This amendment is being filed solely to reflect the modification of the terms of the previously reported purchase on the original form 4 filed on November 21, 2023 (the "Original Form 4"), as agreed to by the registrant and the reporting person on November 22, 2023.